Adnan Mjalli
عدنان المجلي
Born: Tubas, Palestine
Domain: Science & Medicine
Recognition: GLOBAL
Biography
Adnan M. M. Mjalli is a Palestinian-American medicinal chemist and pharmaceutical entrepreneur internationally recognized for his work in drug discovery and the development of new medicines. Born in the West Bank town of Tubas, he earned his PhD in medicinal chemistry from the University of Exeter in the United Kingdom in 1989 and completed postdoctoral research at the University of Rochester. Mjalli built his early career in research and senior management at major pharmaceutical and biotechnology firms, including Merck & Co. and Ontogen Corporation, before founding his own ventures. He is the founder and chief executive of TransTech Pharma and High Point Pharmaceuticals, companies focused on small-molecule drug discovery for metabolic and inflammatory diseases, and has served as chairman of the drug-discovery tools company PharmaCore. He is the author of more than forty scientific papers and several book chapters, and is named as an inventor on more than seven hundred patents and patent applications, an unusually prolific output that reflects a career spanning both fundamental medicinal chemistry and applied pharmaceutical development. His work has contributed to therapeutic programs targeting diabetes and other chronic conditions. Beyond the laboratory, Mjalli has been an active philanthropist and advocate. He has served on the board of the American Task Force on Palestine and supported education, energy, and development initiatives, founding numerous companies across multiple sectors. He is frequently cited as a model of Palestinian achievement in the global pharmaceutical industry. His combination of scientific productivity, entrepreneurial scale, and engagement with Palestinian civic causes makes him a distinctive figure among diaspora scientists, bridging high-level drug discovery with industry leadership.
Why This Person Matters
A Palestinian-American medicinal chemist named on over 700 patents who founded major pharmaceutical companies, exemplifying diaspora scientific achievement at industrial scale.